Versatility of Aminoglycosides and Prospects for Their Future
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
SUMMARY: Aminoglycoside antibiotics have had a major impact on our ability to treat bacterial infections for the past half century. Whereas the interest in these versatile antibiotics continues to be high, their clinical utility has been compromised by widespread instances of resistance. The multitude of mechanisms of resistance is disconcerting but also illuminates how nature can manifest resistance when bacteria are confronted by antibiotics. This article reviews the most recent knowledge about the mechanisms of aminoglycoside action and the mechanisms of resistance to these antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
The Complete Atomic Structure of the Large Ribosomal Subunit at 2.4 Å Resolution
Ban, N., Nissen, P., Hansen, J., Moore, P. B., & Steitz, T. A. (2000) · Science · doi:10.1126/science.289.5481.905 · Cited by 3,327
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Structure of the 30S ribosomal subunit
Wimberly, B. T., Brodersen, D. E., Clemons, W. M., Morgan-Warren, R. J., Carter, A. P., Vonrhein, C., Hartsch, T., & Ramakrishnan, V. (2000) · Nature · doi:10.1038/35030006 · Cited by 2,035 · cited 1×
“and hygromycin B have been solved (12, 27, 45, 117, 257, 306, 315).”
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Yersinia pestis--etiologic agent of plague
Perry, R. D., & Fetherston, J. D. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.35 · Cited by 1,919
Carter, A. P., Clemons, W. M., Brodersen, D. E., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Nature · doi:10.1038/35030019 · Cited by 1,615
Hopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Recognition of Cognate Transfer RNA by the 30 S Ribosomal Subunit
Ogle, J. M., Brodersen, D. E., Clemons, W. M., Tarry, M. J., Carter, A. P., & Ramakrishnan, V. (2001) · Science · doi:10.1126/science.1060612 · Cited by 1,162
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150 · cited 2×
“Tight binding of antibiotic is facilitated by interaction with nucleotides 13, 526, 915, and 1490 of 16S rRNA and protein S12 (45, 105, 186, 191, 196).”
BackgroundMoore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
PCR mapping of integrons reveals several novel combinations of resistance genes
Lévesque, C., Piché, L., Larose, C., & Roy, P. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.185 · Cited by 1,018
Structure of Functionally Activated Small Ribosomal Subunit at 3.3 Å Resolution
Schluenzen, F., Tocilj, A., Zarivach, R., Harms, J., Gluehmann, M., Janell, D., Bashan, A., Bartels, H., Agmon, I., Franceschi, F., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00084-2 · Cited by 979
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 1×
“and hygromycin B have been solved (12, 27, 45, 117, 257, 306, 315).”
Beck, E., Ludwig, G., Auerswald, E. A., Reiss, B., & Schaller, H. (1982) · Gene · doi:10.1016/0378-1119(82)90023-3 · Cited by 921
High Resolution Structure of the Large Ribosomal Subunit from a Mesophilic Eubacterium
Harms, J., Schluenzen, F., Zarivach, R., Bashan, A., Gat, S., Agmon, I., Bartels, H., Franceschi, F., & Yonath, A. (2001) · Cell · doi:10.1016/s0092-8674(01)00546-3 · Cited by 901
An Overview of Human Brucellosis
Young, E. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.283 · Cited by 854
Fourmy, D., Recht, M. I., Blanchard, S. C., & Puglisi, J. D. (1996) · Science · doi:10.1126/science.274.5291.1367 · Cited by 829
Gritz, L., & Davies, J. (1983) · Gene · doi:10.1016/0378-1119(83)90223-8 · Cited by 788
Kinetic amplification of enzyme discrimination
Ninio, J. (1975) · Biochimie · doi:10.1016/s0300-9084(75)80139-8 · Cited by 758
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 672
The staphylococci in human disease
Crossley, K., & Archer, G. L. (1996) · Churchill Livingstone eBooks · Cited by 632
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Bacterial uptake of aminoglycoside antibiotics
Taber, H. W., Mueller, J. P., Miller, P. F., & Arrow, A. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.4.439-457.1987 · Cited by 598
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Nucleotide sequence of the kanamycin resistance transposon Tn903
Oka, A., Sugisaki, H., & Takanami, M. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90438-1 · Cited by 572
ALTERATIONS IN OUTER MEMBRANE PERMEABILITY
Hancock, R. E. W. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.001321 · Cited by 564
Green, R., & Noller, H. F. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.679 · Cited by 564
Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K., & Group, T. S. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1762 · Cited by 539
Takami, H. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4317 · Cited by 533
Integrons and Gene Cassettes in the Enterobacteriaceae
White, P. A., McIver, C. J., & Rawlinson, W. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2658-2661.2001 · Cited by 466
Ito, T., Katayama, Y., & Hiramatsu, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1449 · Cited by 450
Plasmid-Determined Resistance to Antimicrobial Agents
Davies, J., & Smith, D. I. (1978) · Annual Review of Microbiology · doi:10.1146/annurev.mi.32.100178.002345 · Cited by 427
HOW ANTIBIOTIC-PRODUCING ORGANISMS AVOID SUICIDE
Cundliffe, E. (1989) · Annual Review of Microbiology · doi:10.1146/annurev.mi.43.100189.001231 · Cited by 421
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 412
Waites, K., Crouse, D., Nelson, K., Rudd, P., Canupp, K., Ramsey, C., & Cassell, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91002-1 · Cited by 411
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010
Scholz, P., Haring, V., Wittmann-Liebold, B., Ashman, K., Bagdasarian, M., & Scherzinger, E. (1989) · Gene · doi:10.1016/0378-1119(89)90273-4 · Cited by 381
Structural origins of gentamicin antibiotic action
Yoshizawa, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6437 · Cited by 374
Crystal Structure of Paromomycin Docked into the Eubacterial Ribosomal Decoding A Site
Vicens, Q., & Westhof, E. (2001) · Structure · doi:10.1016/s0969-2126(01)00629-3 · Cited by 373
Trieu-Cuot, P., & Courvalin, P. (1983) · Gene · doi:10.1016/0378-1119(83)90022-7 · Cited by 369
Brodersen, D. E., Clemons, W. M., Carter, A. P., Wimberly, B. T., & Ramakrishnan, V. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5359 · Cited by 364
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021
Capela, D., Barloy-Hubler, F., Gouzy, J., Bothe, G., Ampe, F., Batut, J., Boistard, P., Becker, A., Boutry, M., Cadieu, E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161294398 · Cited by 337
Antibiotic Resistance in the ECOR Collection: Integrons and Identification of a Novel aad Gene
Mazel, D., Dychinco, B., Webb, V. A., & Davies, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1568-1574.2000 · Cited by 334
Aminoglycoside Resistance in Enterococci
Chow, J. W. (2000) · Clinical Infectious Diseases · doi:10.1086/313949 · Cited by 332
Structure of Functionally Activated Small Ribosomal Subunit
Schluenzen, F., Tocilj, A., Zarivach, R., et al. (2000) · Cited by 331
Role of pharmacokinetics in the outcome of infections
Drusano, G. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.3.289 · Cited by 330
Once-daily aminoglycoside therapy
Gilbert, D. N. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.399 · Cited by 324
Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever--Reply
Hughes, W. T., Armstrong, D., Bodey, G. P., Feld, R., Mandell, G. L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. C., et al. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.202 · Cited by 319
Hochhut, B., Lotfi, Y., Mazel, D., Faruque, S. M., Woodgate, R., & Waldor, M. K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.2991-3000.2001 · Cited by 318 · cited 2×
“garis (204), Vibrio cholerae (24, 126), Campylobacter jejuni”
BackgroundPostantibiotic Suppression of Bacterial Growth
Bundtzen, R. W., Gerber, A. U., Cohn, D. L., & Craig, W. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.28 · Cited by 311
Gales, A. C., Jones, R. N., Turnidge, J., Rennie, R., & Ramphal, R. (2001) · Clinical Infectious Diseases · doi:10.1086/320186 · Cited by 309
Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei
Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.465 · Cited by 305
Killing and regrowth of bacteria in vitro: a review.
Craig, W. A., & Ebert, S. C. (1990) · PubMed · Cited by 303
Studies on antibiotic synergism against enterococci
Moellering, R. C., & Weinberg, A. N. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106758 · Cited by 302
Ferretti, J. J., Gilmore, K. S., & Courvalin, P. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.2.631-638.1986 · Cited by 301
Low, D. E., Keller, N., Barth, A., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320185 · Cited by 289
Paromomycin binding induces a local conformational change in the A-site of 16 s rRNA
Fourmy, D., Yoshizawa, S., & Puglisi, J. D. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1551 · Cited by 270
AcrD of Escherichia coli Is an Aminoglycoside Efflux Pump
Rosenberg, E. Y., Ma, D., & Nikaido, H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1754-1756.2000 · Cited by 256
Schatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 251
Beaber, J. W., Hochhut, B., & Waldor, M. K. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.15.4259-4269.2002 · Cited by 248 · cited 1×
“Recently, the aph(3 )-Ib-aph(6)-Id genes were found on a Tn5393-like transposon from a fish pathogen (154), on an integron from Pseudomonas aeruginosa (208), and on a conjugative transposon-like mobile genetic element from Vibrio cholerae (15, 126).”
BackgroundAntibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli
Sigmund, C. D., Ettayebi, M., & Morgan, E. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.11.4653 · Cited by 243
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice
Freeman, C. D., Nicolau, D. P., Belliveau, P. P., & Nightingale, C. H. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.6.677 · Cited by 242
Hon, W.-C., McKay, G. A., Thompson, P. R., Sweet, R. M., Yang, D. S. C., Wright, G. D., & Berghuis, A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80274-3 · Cited by 241
Prammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
Streptomycin and Alternative Agents for the Treatment of Tularemia: Review of the Literature
Enderlin, G., Morales, L., Jacobs, R. F., & Cross, J. T. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.1.42 · Cited by 234
Antimicrobial Therapy and Vaccines
Weber (2002) · Cited by 234
Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 s rRNA
Fourmy, D., Recht, M. I., & Puglisi, J. D. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1552 · Cited by 230
CRAIG, W. A., & VOGELMAN, B. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-900 · Cited by 228
Vancomycin resistance in staphylococci
Hiramatsu, K. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80029-0 · Cited by 227
The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options
Moellering, R. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.1.1 · Cited by 225
Ratjen, F., Döring, G., & Nikolaizik, W. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06124-4 · Cited by 218
A Conformational Switch in Escherichia coli 16 S Ribosomal RNA During Decoding of Messenger RNA
Lodmell, J. S., & Dahlberg, A. E. (1997) · Science · doi:10.1126/science.277.5330.1262 · Cited by 212
Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenyltransferase
Hollingshead, S., & Vapnek, D. (1985) · Plasmid · doi:10.1016/0147-619x(85)90052-6 · Cited by 211
Boyd, D., Cloeckaert, A., Chaslus-Dancla, E., & Mulvey, M. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1714-1722.2002 · Cited by 209 · cited 6×
“I genes have been identified frequently among various clinical isolates of Enterobacteriaceae (26, 165, 182, 253, 313), Pseudomonas aeruginosa (207), and Vibrio cholerae (66–68, 84).”
BackgroundInfluentialDetection of a Streptomycin/Spectinomycin Adenylyltransferase Gene ( aadA ) in Enterococcus faecalis
Clark, N. C., Olsvik, Ø., Swenson, J. M., Spiegel, C. A., & Tenover, F. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.157 · Cited by 202
Persistent Effect of Antibiotics on Staphylococcus aureus after Exposure for Limited Periods of Time
McDonald, P. J., Craig, W. A., & Kunin, C. M. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/135.2.217 · Cited by 196
SUNDIN, G. W., & BENDER, C. L. (1996) · Molecular Ecology · doi:10.1111/j.1365-294x.1996.tb00299.x · Cited by 195 · cited 1×
“In contrast to the majority of plant bacteria, the aph(3 )-Ib-aph(6)-Id genes from human and animal pathogens were found to be associated with small nonconjugative plasmids of gram-negative microorganisms (73, 145, 279).”
BackgroundAntibiotic combinations: should they be tested?
Eliopoulos, G. M., & Eliopoulos, C. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.139 · Cited by 189
R391: a Conjugative Integrating Mosaic Comprised of Phage, Plasmid, and Transposon Elements
Böltner, D., MacMahon, C., Pembroke, J. T., Strike, P., & Osborn, A. M. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.18.5158-5169.2002 · Cited by 187
Chiou, C. S., & Jones, A. L. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.3.732-740.1993 · Cited by 185
Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium
Costa, Y., Galimand, M., Leclercq, R., Duval, J., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1896 · Cited by 185
Ploy, M.-C., Denis, F., Courvalin, P., & Lambert, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2684-2688.2000 · Cited by 185
Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics
Damper, P. D., & Epstein, W. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.6.803 · Cited by 180
Bryan, L. E., Kowand, S. K., & Van Den Elzen, H. M. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.1.7 · Cited by 179
Codon-specific missense errors in vivo.
Bouadloun, F., Donner, D., & Kurland, C. G. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01591.x · Cited by 176
Berg, T., Firth, N., Apisiridej, S., Hettiaratchi, A., Leelaporn, A., & Skurray, R. A. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4350-4359.1998 · Cited by 174
Sundin, G. W., & Bender, C. L. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.4.1018-1024.1993 · Cited by 173
Cameron, F. H., Groot Obbink, D. J., Ackerman, V. P., & Hall, R. M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.21.8625 · Cited by 167
Llano-Sotelo, B., Azucena, E. F., Kotra, L. P., Mobashery, S., & Chow, C. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00125-4 · Cited by 167
Self-citationAminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition
Azucena, E., & Mobashery, S. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0197 · Cited by 166
Self-citationBissonnette, L., & Roy, P. H. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.4.1248-1257.1992 · Cited by 166
Design of Novel Antibiotics that Bind to the Ribosomal Acyltransfer Site
Haddad, J., Kotra, L. P., Llano-Sotelo, B., Kim, C., Azucena, E. F., Liu, M., Vakulenko, S. B., Chow, C. S., & Mobashery, S. (2002) · Journal of the American Chemical Society · doi:10.1021/ja011695m · Cited by 164
Self-citationLiposome-encapsulated aminoglycosides in pre-clinical and clinical studies
Schiffelers, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.333 · Cited by 163
(1984) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040298 · Cited by 162
Thompson, C. J., & Gray, G. S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5190 · Cited by 158
Poirel, L., Karim, A., Mercat, A., Thomas, I., Vahaboğlu, H., Richard, C., & Nordmann, P. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.157 · Cited by 156
Long-term Benefits of Inhaled Tobramycin in Adolescent Patients With Cystic Fibrosis
Moss, R. B. (2002) · CHEST Journal · doi:10.1378/chest.121.1.55 · Cited by 156
Carattoli, A., Tosini, F., Giles, W., Rupp, M. E., Hinrichs, S. H., Angulo, F. J., Barrett, T. J., & Fey, P. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1269-1272.2002 · Cited by 153
Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria
Maurin, M., & Raoult, D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.2977-2986.2001 · Cited by 151
Thungapathra, M., Amita, Sinha, K. K., Chaudhuri, S. R., Garg, P., Ramamurthy, T., Nair, G. B., & Ghosh, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2948-2955.2002 · Cited by 150
Aminoglycoside antibiotics. Structures, functions, and resistance.
Wright, G. D., Berghuis, A. M., & Mobashery, S. (1998) · PubMed · Cited by 146
Self-citationAminoglycoside Antibiotics: Structures, Functions, and Resistance
Wright, G. D., Berghuis, A. M., & Mobashery, S. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4897-3_4 · Cited by 138
Self-citationTosini, F., Visca, P., Luzzi, I., Dionisi, A. M., Pezzella, C., Petrucca, A., & Carattoli, A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3053 · Cited by 136
Resistance of Enterococci to Aminoglycosides and Glycopeptides
Leclercq, R., Dutka‐Malen, S., Brisson-Noël, A., Molinas, C., Derlot, E., Arthur, M., Duval, J., & Courvalin, P. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.495 · Cited by 134
Murphy, E. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00383309 · Cited by 132
Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host
Denning, D. W. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_b.1 · Cited by 128
Dalsgaard, A. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.827 · Cited by 126
Nucleotide sequence of tbe hygromycin B phosphotransferase gene fromStreptomyces hygroscopicus
Zalacaín, M., González, A. G., Guerrero, M. C., Mattaliano, R. J., Malpartida, F., & Jiménez, A. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.4.1565 · Cited by 126
Miller, M. H., Edberg, S. C., Mandel, L. J., Behar, C. F., & Steigbigel, N. H. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.5.722 · Cited by 125
SHIMIZU, K., 熊田, 徹., Hsieh, W. C., Chung, H. Y., Chong, Y., Hare, R. S., Miller, G. H., Sabatelli, F., & Howard, J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.282 · Cited by 123
New (and not so new) antibacterial targets – from where and when will the novel drugs come?
Projan, S. J. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00197-2 · Cited by 122
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
Ma, S., & Kb, C. (1976) · PubMed · Cited by 119
Dalsgaard, A., Forslund, A., Serichantalergs, O., & Sandvang, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1315-1321.2000 · Cited by 118
NeÅ¡vera, J., Hochmannová, J., & Pátek, M. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13345.x · Cited by 118
Karimi, R., & Ehrenberg, M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb20059.x · Cited by 118
Genomics and Antimicrobial Drug Discovery
Moir, D. T., Shaw, K. J., Hare, R. S., & Vovis, G. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.439 · Cited by 116
Inhibition of Aminoglycoside Antibiotic Resistance Enzymes by Protein Kinase Inhibitors
Daigle, D. M., McKay, G. A., & Wright, G. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24755 · Cited by 114
E. coli ribosomes with a C912 to U base change in the 16S rRNA are streptomycin resistant.
Montandon, P.-E., Wagner, R., & Stutz, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04703.x · Cited by 112
Streptomycin preferentially perturbs ribosomal proofreading
Ruusala, T., & Kurland, C. G. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328707 · Cited by 110
Gentamicin interaction with Pseudomonas aeruginosa cell envelope
Martin, N., & Beveridge, T. J. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.6.1079 · Cited by 109
A novel gentamicin resistance gene in Enterococcus
Chow, J. W., Zervos, M., Lerner, S. A., Thal, L. A., Donabedian, S. M., Jaworski, D. D., Tsai, S., Shaw, K. J., & Clewell, D. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.511 · Cited by 109
Kobayashi, N., Alam, M. M., Nishimoto, Y., Urasawa, S., Uehara, N., & Watanabe, N. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005271 · Cited by 108
Wright, G. D., & Ladak, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.956 · Cited by 107
Frana, T. S., Carlson, S. A., & Griffith, R. W. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.1.445-448.2001 · Cited by 104
A mutation in the 530 loop ofEscherichia coli16S ribosomal RNA causes resistance to streptomycin
Melançon, P., Lemieux, C., & Brakier‐Gingras, L. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.20.9631 · Cited by 104
Boerlin, P., Burnens, A. P., Frey, J., Kuhnert, P., & Nicolet, J. (2001) · Veterinary Microbiology · doi:10.1016/s0378-1135(00)00347-3 · Cited by 103
Ida, T., Okamoto, R., Shimauchi, C., Okubo, T., Kuga, A., & Inoue, M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3115-3121.2001 · Cited by 103
Falbo, V., Carattoli, A., Tosini, F., Pezzella, C., Dionisi, A. M., & Luzzi, I. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.693 · Cited by 101
Tauch, A., Krieft, S., Kalinowski, J., & Pühler, A. (2000) · Molecular and General Genetics MGG · doi:10.1007/pl00008668 · Cited by 100
Administration of Aerosolized Antibiotics in Cystic Fibrosis Patients
Moss, R. B. (2001) · CHEST Journal · doi:10.1378/chest.120.3_suppl.107s · Cited by 98
A New High-Level Gentamicin Resistance Gene, aph(2")-Id , in Enterococcus spp
Tsai, S. F., Zervos, M. J., Clewell, D. B., Donabedian, S. M., Sahm, D. F., & Chow, J. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1229 · Cited by 97
Epidemiological studies of aminoglycoside resistance in the U.S.A.
PRICE, K. E., Kresel, P. A., Farchione, L., Siskin, S. B., & Karpow, S. A. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/8.suppl_a.89 · Cited by 96
Calderwood, S. A., Wennersten, C. B., Moellering, R. C., Kunz, L. J., & Krogstad, D. J. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.3.401 · Cited by 94
Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci
Ounissi, H., Derlot, E., Carlier, C., & Courvalin, P. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2164 · Cited by 94
Naas, T., Sougakoff, W., Casetta, A., & Nordmann, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2074 · Cited by 92
Sundin, G. W., & Bender, C. L. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.8.2891-2897.1995 · Cited by 91
Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes.
Barza, M. J., Stuart, M., & Szoka, F. C. (1987) · PubMed · Cited by 91
Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design
Ebert, S. C., & Craig, W. A. (1990) · Infection Control and Hospital Epidemiology · doi:10.1086/646178 · Cited by 91
Fantin, B., Ebert, S. C., Leggett, J., Vogelman, B., & Craig, W. A. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.6.829 · Cited by 91
Kinetic Mechanism of Aminoglycoside Phosphotransferase Type IIIa
McKay, G. A., & Wright, G. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24686 · Cited by 90
L'Abée-Lund, T. M., & Sørum, H. R. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.12.5533-5535.2000 · Cited by 89
Flung, M. E., Kopf, J., & Richards, C. A. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.19.7095 · Cited by 88
Majumdar, S., Flasher, D., Friend, D. S., Nassos, P., Yajko, D., Hadley, W. K., & Düzgüneş, N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2808 · Cited by 86
Martin, P., Jullien, E., & Courvalin, P. M. (1988) · Molecular Microbiology · doi:10.1111/j.1365-2958.1988.tb00070.x · Cited by 85
30S Ribosomal Subunit Assembly Is a Target for Inhibition by Aminoglycosides in Escherichia coli
Mehta, R., & Champney, W. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1546-1549.2002 · Cited by 83
Role of aminoglycosides in the treatment of bacterial endocarditis
Graham, J., & Gould, F. K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.437 · Cited by 81
How β-Lactamases Have Driven Pharmaceutical Drug Discovery
Bush, K., & Mobashery, S. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4897-3_5 · Cited by 79
Self-citationRochon-Edouard, S., Pestel‐Caron, M., Lemeland, J., & Caron, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3055-3060.2000 · Cited by 79
Werner, G., Hildebrandt, B., & Witte, W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3267-3269.2001 · Cited by 77
Dalsgaard, A., Forslund, A., Tam, N. V., Vinh, D. X., & Cam, P. D. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.3.734-741.1999 · Cited by 75
Ribosomal resistance of clinical enterococcal to streptomycin isolates
Eliopoulos, G. M., Farber, B. F., Murray, B. E., Wennersten, C., & Moellering, R. C. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.3.398 · Cited by 75
Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin
Swenson, C. E., Stewart, K. A., Hammett, J. L., Fitzsimmons, W. E., & Ginsberg, R. S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.235 · Cited by 75
Fountain, M. W., Weiss, S. J., Fountain, A. G., Shen, A., & Lenk, R. P. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/152.3.529 · Cited by 74
Dixon, L. G., Albritton, W. L., & Willson, P. J. (1994) · Plasmid · doi:10.1006/plas.1994.1060 · Cited by 73
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates
Shaw, K. J., Hare, R. S., Sabatelli, F., Rizzo, M. F., Cramer, C. A., Naples, L., Kocsi, S., MUNAYYER, H., Mann, P. A., & Miller, G. H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2253 · Cited by 72
Quittner, A. L., & Buu, A. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10074 · Cited by 71
Miller, G. H., Sabatelli, F., Naples, L., Hare, R. S., & Shaw, K. J. (1995) · PubMed · Cited by 71
Payie, K. G., Rather, P. N., & Clarke, A. J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.15.4303-4310.1995 · Cited by 68
Bryan, L. E. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-138120-2.50013-7 · Cited by 67
Dissociation rates of peptidyl‐tRNA from the P‐site of E.coli ribosomes.
Karimi, R., & Ehrenberg, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00453.x · Cited by 65
Complete Nucleotide Sequence of Plasmid Rts1: Implications for Evolution of Large Plasmid Genomes
Murata, T., Ohnishi, M., Ara, T., Kaneko, J., Han, C.-G., Li, Y. F., Takashima, K., Nojima, H., Nakayama, K., Kaji, A., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.12.3194-3202.2002 · Cited by 65
Wilson, D. N., Blaha, G. M., Connell, S. R., Ivanov, P. V., Jenke, H., Stelzl, U., Teraoka, Y., & Nierhaus, K. H. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380846 · Cited by 63
Hasdemir, U. O., Gür, D., Ünal, S., & Miller, G. H. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00284.x · Cited by 63
New antibiotic discovery, novel screens, novel targets and impact of microbial genomics
Allsop, A. E. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80085-4 · Cited by 62
Leigh, D. A., Bradnock, K., & Marriner, J. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/7.3.229 · Cited by 62
Sandvang, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.3036 · Cited by 60
Rosen, B. P., & Mobashery, S. (1998) · Medical Entomology and Zoology · Cited by 59
Self-citationHächler, H., Santanam, P., & Kayser, F. H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1254 · Cited by 59
Cross-linking of streptomycin to the 16S ribosomal RNA of Escherichia coli
Gravel, M., Melançon, P., & Brakier‐Gingras, L. (1987) · Biochemistry · doi:10.1021/bi00393a041 · Cited by 58
Heinzl, B., Eber, E., Oberwaldner, B., Haas, G., & Zach, M. S. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.10019 · Cited by 58
Lambert, T., Gerbaud, G., Galimand, M., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2093 · Cited by 57
Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes
Tadakuma, T., Ikewaki, N., Yasuda, T., Tsutsumi, M., Saito, S., & Saito, K. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.1.28 · Cited by 56
Hessen, M. T., Pitsakis, P. G., & Levison, M. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.5.608 · Cited by 55
Hannecart-Pokorni, E., Depuydt, F., Wit, L. D., Bossuyt, E. V., Content, J., & Vanhoof, R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.314 · Cited by 54
Intravitreal liposome-encapsulated drugs: A preliminary human report
Peyman, G. A., Charles, H. C., Liu, K. R., Khoobehi, B., & Niesman, M. R. (1988) · International Ophthalmology · doi:10.1007/bf00130002 · Cited by 53
Ribosomal Resistance to Streptomycin and Spectinomycin in Neisseria gonorrhoeae
Maness, M. J., Foster, G. C., & Sparling, P. F. (1974) · Journal of Bacteriology · doi:10.1128/jb.120.3.1293-1299.1974 · Cited by 52
Kim, E.-H., & Aoki, T. (1994) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1994.tb01741.x · Cited by 52
Single Daily Dosing of Aminoglycosides
Preston, S. L., & Briceland, L. L. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04368.x · Cited by 51
Wrighton, C. J., & Strike, P. (1987) · Plasmid · doi:10.1016/0147-619x(87)90006-0 · Cited by 51
Aminoglycoside-modifying enzymes of Staphylococcus aureus; Experssion in Escherichia coli
Courvalin, P. M., & Fiandt, M. (1980) · Gene · doi:10.1016/0378-1119(90)90326-m · Cited by 51
Gates, C. A., & Northrop, D. B. (1988) · Biochemistry · doi:10.1021/bi00410a045 · Cited by 50
Tenover, F. C., Gilbert, T., & O’Hara, P. J. (1989) · Plasmid · doi:10.1016/0147-619x(89)90035-8 · Cited by 50
Gangadharam, P. R., Ashtekar, D. R., Flasher, D. L., & Düzgüneş, N. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.725 · Cited by 49
Biddlecome, S., Haas, M. J., DAVIES, J. E., Miller, G. H., Rane, D. F., & Daniels, P. J. L. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.6.951 · Cited by 49
Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci
Carlier, C., & Courvalin, P. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1565 · Cited by 48
Azucena, E., Grapsas, I., & Mobashery, S. (1997) · Journal of the American Chemical Society · doi:10.1021/ja964278w · Cited by 47
Self-citationIntravitreal Pharmacokinetics of Liposome-encapsulated Amikacin in a Rabbit Model
Shuiqing, Z., Hu, C., Houren, W., Lu, Y., Zhang, Y., Yang, J., Yun, G., Zou, W., & Song, B. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31423-5 · Cited by 45
Detection of apramycin resistant enterobacteriaceae in hospital isolates
Chaslus-Dancla, E., Glupczynski, Y., Gerbaud, G., Lagorce, M., Lafont, J. P., & Courvalin, P. M. (1989) · FEMS Microbiology Letters · doi:10.1016/0378-1097(89)90208-5 · Cited by 44
Sundin, G. W. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.848 · Cited by 44
Naas, T., Poirel, L., & Nordmann, P. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00202-x · Cited by 40
Tenover, F. C., Phillips, K. L., Gilbert, T. L., Lockhart, P. G., O’Hara, P. J., & Plorde, J. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.551 · Cited by 40
Chinault, A. C., Blakesley, V. A., Roessler, E., Willis, D. G., Smith, C. A., Cook, R. G., & Fenwick, R. G. (1986) · Plasmid · doi:10.1016/0147-619x(86)90048-x · Cited by 39
Cited by
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Taxonomy, Physiology, and Natural Products of Actinobacteria
Barka, E. A., Vatsa, P., Sanchez, L., Gaveau-Vaillant, N., Jacquard, C., Klenk, H.-P., Clément, C., Ouhdouch, Y., & van Wezel, G. P. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00019-15 · Cited by 2,188
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Metadata
- Authors
- Vakulenko, S. B., & Mobashery, S.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2003-07
- Volume
- 16
- Issue
- 3
- Pages
- 430-450
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2110424949
- Cited by
- 643
- References
- 221
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.